Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
300255.SZFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
144
Cost of Revenue
131
Gross Profit
13
Gross Margin
9.1%
Operating Income
-36
Operating Margin
-24.6%
Net Income
-35
Net Margin
-24.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-15
EBITDA Margin
-10.4%
2023
12/31/2023
Revenue
197
Cost of Revenue
243
Gross Profit
-45
Gross Margin
-22.9%
Operating Income
-172
Operating Margin
-86.9%
Net Income
-174
Net Margin
-87.9%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-150
EBITDA Margin
-75.9%
2022
12/31/2022
Revenue
327
Cost of Revenue
184
Gross Profit
143
Gross Margin
43.7%
Operating Income
3
Operating Margin
0.9%
Net Income
2
Net Margin
0.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
23
EBITDA Margin
7.1%
2021
12/31/2021
Revenue
416
Cost of Revenue
174
Gross Profit
241
Gross Margin
58.0%
Operating Income
37
Operating Margin
8.8%
Net Income
33
Net Margin
7.9%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
53
EBITDA Margin
12.8%
2020
12/31/2020
Revenue
331
Cost of Revenue
104
Gross Profit
227
Gross Margin
68.5%
Operating Income
43
Operating Margin
13.1%
Net Income
35
Net Margin
10.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
59
EBITDA Margin
17.9%